Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Categories
Subscribe to the Magazine for free
Subscribe for free to keep reading! If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Understanding BNP Hormone Level: A Guide to Heart Health

Medically reviewed by 
 
Understanding BNP Hormone Level: A Guide to Heart Health

B-type Natriuretic Peptide, or BNP, is a hormone secreted by the heart's ventricles and serves as an important indicator of heart health. Normally, BNP levels are kept within a certain range by the body. However, when BNP levels rise, it often points to heart problems, particularly heart failure.

This article will explore the details of BNP, explaining its role and the various tests used to measure its levels. Additionally, we'll discuss effective lifestyle choices and management strategies to maintain a healthy heart.

[signup]

What Is BNP?

B-type Natriuretic Peptide (BNP) is a cardiovascular hormone with functions in blood pressure regulation, fluid status, and cardiac contractility. BNP is produced and released mainly in the cardiac ventricles in response to increased ventricular wall stretching. BNP is a vasodilator, so it decreases systemic vascular resistance and reduces blood pressure. It also inhibits renin and aldosterone secretion. All in all, these effects reduce cardiac workload to optimize cardiac output.

BNP levels can be used to help diagnose and monitor a variety of cardiovascular conditions, and it is especially useful in the diagnosis of heart failure. Elevated BNP levels are often indicative of myocardial stress and dysfunction. They are a reliable biomarker for assessing the presence and severity of heart failure. When the differential diagnosis is broad, elevated BNP levels suggest heart failure as a likely etiology.

The Function of BNP in the Body

As it is primarily made in the cardiac ventricles, the most integral role of the BNP hormone is the regulation of blood pressure and fluid homeostasis. Through its action as a vasodilator, BNP aids circulation by decreasing systemic vascular resistance and reducing blood pressure. Its additional role in the inhibition of renin and aldosterone secretion is another mechanism by which BNP promotes overall diuresis and reduction in fluid volume. Cumulatively, BNP helps prevent fluid overload and maintain normotension.

BNP is a valuable biomarker for many cardiac conditions, chiefly heart failure. Elevated BNP levels signal myocardial stress and dysfunction, which is helpful not only in the diagnosis of heart failure but also in the prognosis and risk stratification of heart failure patients. BNP levels are useful to help formulate treatment plans for heart failure and then monitor the response to therapy, helping improve patient outcomes. 

BNP vs. NT-proBNP

BNP (B-type Natriuretic Peptide) and NT-proBNP (N-terminal pro-B-type Natriuretic Peptide) are similar biomarkers, both used in diagnosing and treating heart failure, but with several key differences. BNP is the biologically active hormone produced and released directly by cardiac ventricles in response to increased stress on the myocardium or volume overload. NT-proBNP is an inactive fragment cleaved from the precursor proBNP molecule during BNP synthesis. 

Both markers are released into the blood during cardiac stress, but their half-lives are different. NT-proBNP has a much longer half-life than BNP. Clinically, BNP and NT-proBNP can each be used to diagnose heart failure and assess its severity, as their levels correlate well with disease progression and prognosis.

Performance BNP Levels and Heart Health

Elevated levels of BNP can result from several cardiovascular conditions, including heart failure, myocardial infarction, and severe hypertension. In heart failure, increased ventricular pressure and volume overload trigger the production of BNP to help relieve cardiac stress. 

When myocardial damage and ischemia occur in a myocardial infarction, the resulting cardiac injury also prompts the release of BNP. Uncontrolled or severe hypertension often results in cardiac hypertrophy and strain, which then causes the release of BNP.

Causes of Elevated BNP Levels

In addition to cardiovascular conditions like heart failure, myocardial infarction, and severe hypertension, many non-cardiac conditions, like kidney dysfunction, critical illness, obesity, and even older age can affect BNP levels. 

Kidney dysfunction reduces the clearance of BNP, leading to increased levels in the blood. Obesity leads to increased production of BNP through adipocytes. Increasing age often leads to impaired kidney function and changes in the structure and function of the heart, all of which can lead to elevated BNP levels.

Interpreting BNP Test Results

Understanding BNP test results helps assess a patient’s cardiac health status when interpreted correctly. 

  • Normal BNP levels usually range from 0 to 100 pg/mL, depending on the specific test and lab interpretation. 
  • Elevated BNP levels, usually above 400 pg/mL, are suggestive of heart failure. The severity of the condition can correlate with the degree of BNP elevation, with higher levels indicating more severe disease or the risk of poor outcomes
  • However, many patients with heart failure have elevated BNP levels at baseline, so it is important to monitor baseline levels of BNP when assessing for possible heart failure exacerbation.

Serial measurements of BNP levels are controversial. Studies suggest that regular monitoring of BNP levels in annual or every 6-month intervals may be helpful to assess disease progression and severity. 

Consistent monitoring may facilitate earlier detection of disease progression and allow for timely adjustments in treatment regimens, thus improving patient outcomes. However, frequent serial checks, such as daily or every few days in heart failure exacerbations, have not shown to be useful in assessing treatment response. 

The BNP Test: What to Expect

The BNP blood test is a simple laboratory test obtained as a blood sample. Fasting or other special preparations are not necessary. Aside from regular hydration, patients can proceed in their normal routines after a BNP test is performed. 

Healthcare providers often order a BNP test when acute heart failure is suspected. Symptoms of heart failure may include such as shortness of breath, edema, weight gain, or fatigue. A BNP level may also be ordered as part of serial monitoring in patients with known heart failure.

Lifestyle and Management Strategies for Heart Health

Lifestyle changes play a crucial role in promoting heart health and may positively impact BNP levels. 

Eating a Heart-Healthy Diet

  • Adopting a heart-healthy diet rich in fruits, vegetables, whole grains, healthy fats, and lean proteins, all while limiting sodium, trans fats, added sugars, and other processed foods, will help control blood pressure and reduce stress on the heart. 

Engaging in Regular Physical Activity

  • Regular physical exercise is crucial in maintaining a healthy weight. 
  • Regular exercise also strengthens the heart muscle and improves overall cardiovascular function. 

Managing Stress Levels

  • Stress management techniques are incredibly important to reduce the negative effects that chronic stress can place on the heart. 
  • Consider meditation, yoga, prayer, deep breathing exercises, hobbies, and time with family and friends. 

Other Lifestyle Changes

  • Avoiding smoking and alcohol use will have substantial positive impacts on cardiovascular health. 
  • Consistent medication adherence as prescribed by healthcare providers is imperative to control underlying medical conditions and optimize cardiovascular health.

Medications and Treatments Affecting BNP Levels

Medications and treatments for heart failure and other cardiovascular diseases can influence BNP levels. 

Drugs like angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), beta-blockers, and diuretics are commonly prescribed to treat heart failure, and they can have varying effects on BNP levels

Additionally, some medications exacerbate heart failure symptoms, and still others increase the workload of the heart, potentially causing elevated BNP levels. 

No consistent evidence recommends serial monitoring of BNP levels in response to specific medications. However, it is essential to discuss with a knowledgeable healthcare professional how certain medications could impact BNP levels.

[signup]

Key Takeaways

  • B-type Natriuretic Peptide (BNP) is a helpful hormone in assessing heart health. It is secreted by the heart to regulate blood pressure and fluid homeostasis. 
  • Cardiovascular conditions that may lead to an elevated BNP level include heart failure, myocardial infarction, and severe hypertension. 
  • Non-cardiovascular conditions that may cause a high BNP level are kidney dysfunction, obesity, and older age. 
  • Regular monitoring of BNP levels may be helpful in assessing cardiovascular disease progression and severity to allow for timely adjustments in treatment regimens, thus improving patient outcomes. 
  • Lifestyle changes and consistent medication adherence are important in promoting heart health and improving BNP levels.
The information provided is not intended to be a substitute for professional medical advice. Always consult with your doctor or other qualified healthcare provider before taking any dietary supplement or making any changes to your diet or exercise routine.
Learn More
No items found.

Lab Tests in This Article

References

Anderson, S. (2022, May 19). 6 Preventable Risk Factors Associated with Heart Attacks. Rupa Health. https://www.rupahealth.com/post/5-things-to-do-after-a-heart-attack

B-Type Natriuretic Peptide (BNP) Test. (2022, March 3). Cleveland Clinic. https://my.clevelandclinic.org/health/diagnostics/22629-b-type-natriuretic-peptide

Buchan TA, Ching C, Foroutan F, et al. Prognostic value of natriuretic peptides in heart failure: systematic review and meta-analysis. Heart Fail Rev. 2022;27(2):645-654. https://pubmed.ncbi.nlm.nih.gov/34227029/#:~:text=Moderate%20to%20high%2Dquality%20evidence,increased%20hazard%20of%20mortality%20or

Cloyd, J. (2023, October 10). A Functional Medicine Approach to Stress Management. Rupa Health. https://www.rupahealth.com/post/a-functional-medicine-approach-to-stress-management

Cloyd, J. (2023, April 10). A Functional Medicine Hypertension Protocol. Rupa Health. https://www.rupahealth.com/post/functional-medicine-hypertension-protocol

Cloyd, J. (2024, January 24). Cardiac Risk Assessment: When to Utilize Troponin and NT-proBNP Tests. Rupa Health.  https://www.rupahealth.com/post/cardiac-risk-assessment-when-to-utilize-troponin-and-nt-probnp-tests

Cloyd, J. (2024, January 8). The Science of Hydration: How Water Affects Overall Health. https://www.rupahealth.com/post/the-science-of-hydration-how-water-intake-affects-overall-health

DePorto, T. (2022, December 9). Functional Medicine Lab Tests for Heart Disease. Rupa Health. https://www.rupahealth.com/post/worried-about-heart-disease-ask-your-provider-for-these-6-specialty-labs-at-your-next-appointment

Khakham, C. (2023, March 28). An Integrative Medicine Approach to Kidney Disease. Rupa Health. https://www.rupahealth.com/post/an-integrative-medicine-approach-to-kidney-disease

Khakham, C. (2023, April 6). Understanding Your Risk of Cardiovascular Disease With Functional Medicine Labs. Rupa Health. https://www.rupahealth.com/post/understanding-your-risk-of-cardiovascular-disease-with-functional-medicine-labs

Khakham, C. (2023, June 1). Integrative Cardiology: Lifestyle and Natural Approaches to Heart Health. Rupa Health. https://www.rupahealth.com/post/integrative-cardiology-lifestyle-and-natural-approaches-to-heart-health

Ikeda S, Shinohara K, Enzan N, et al. Serial measurement of B-type natriuretic peptide and future cardiovascular events in patients with type 2 diabetes mellitus without known cardiovascular disease. Int J Cardiol. 2022;356:98–104. https://pubmed.ncbi.nlm.nih.gov/35354080/

Mayo Clinic. (2023, August 16). Angiotensin-converting enzyme (ACE) inhibitors. https://www.mayoclinic.org/diseases-conditions/high-blood-pressure/in-depth/ace-inhibitors/art-20047480

Mayo Clinic. (2023, August 4). Angiotensin II receptor blockers. https://www.mayoclinic.org/diseases-conditions/high-blood-pressure/in-depth/angiotensin-ii-receptor-blockers/art-20045009

Miller WL. Serial, Repeated, or Single Measurements of Natriuretic Peptides (BNP or NT-proBNP) in Estimating Cardiovascular Risk: Is It the "Importance of Change Over Time" or "The Past Is Good, But the Present Is Better," or Both, in Clinical Context?. J Am Heart Assoc. 2022;11(8):e025294. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238445/

Myhre PL, Vaduganathan M, Claggett B, et al. B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan: The PARADIGM-HF Trial. J Am Coll Cardiol. 2019;73(11):1264-1272. https://pubmed.ncbi.nlm.nih.gov/30846338/

Neibling, K. (2023, April 26). Complementary and Integrative Medicine Treatments for Hypertension and Cardiovascular Disease. Rupa Health. https://www.rupahealth.com/post/complementary-and-integrative-medicine-treatments-for-hypertension-and-cardiovascular-disease

Ontario Health (Quality) . Use of B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP (NT-proBNP) as Diagnostic Tests in Adults With Suspected Heart Failure: A Health Technology Assessment. Ont Health Technol Assess Ser. 2021;21(2):1–125. https://pubmed.ncbi.nlm.nih.gov/34055110/

Palazzuoli A, Gallotta M, Quatrini I, Nuti R. Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in heart failure. Vasc Health Risk Manag. 2010;6:411–418. https://pubmed.ncbi.nlm.nih.gov/20539843/

Rumman R, Venus K. Preoperative B-type natriuretic peptide testing in patients undergoing noncardiac surgery. CMAJ. 2022;194(39):E1350. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616157/

van Veldhuisen DJ, Linssen GC, Jaarsma T, et al. B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction. J Am Coll Cardiol. 2013;61(14):1498–1506. https://pubmed.ncbi.nlm.nih.gov/23500300/

Yoshimura, H. (2023, November 7). The Remarkable Power of Exercise on Our Health: A Comprehensive Overview. Rupa Health. https://www.rupahealth.com/post/the-remarkable-power-of-exercise-on-our-health-a-comprehensive-overview

Varinasi-Diaz, S. (2023, March 18). Are Your Patients on Antihypertensive Drugs? How Root Cause Medicine Can Complement Their Treatment. Rupa Health. https://www.rupahealth.com/post/are-your-patients-on-antihypertensive-drugs-how-root-cause-medicine-can-complement-their-treatment

Weinberg, JL. (2022, November 16). What is The Mediterranean Diet? Rupa Health. https://www.rupahealth.com/post/4-science-backed-health-benefits-of-the-mediterranean-diet

Subscribe to the Magazine for free. to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.